Concepedia
Statistics
Publications
16
Citations
876
H-Index
14
Active since
2014
Affiliations
University of Vermont(Current)
California Institute for Biomedical Research
Scripps Research Institute
Novartis (Switzerland)
Novartis (United States)
Rajiv S. Jumani is an author at University of Vermont specializing in medicine, drug discovery, and pharmacology.
Top concepts
MedicinePharmacologyDrug DiscoveryPathologyBiochemistryNatural SciencesMedicinal ChemistryHealthImmunologyMicrobiology
Publications per year
2014–2024
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
Beatriz Baragaña, Barbara Forte, Ryan Choi et al. · Proceedings of the National Academy of Sciences · 2019 · 132 citations · Full text
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis
Melissa S. Love, Federico C. Beasley, Rajiv S. Jumani et al. · PLoS neglected tropical diseases · 2017 · 123 citations · Full text
Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis
Vitul Jain, M. Yogavel, Haruhisa Kikuchi et al. · Structure · 2017 · 94 citations
Drug Target, Biochemistry, Antiparasitic Agent +7
Identification of Cryptosporidium parvum Active Chemical Series by Repurposing the Open Access Malaria Box
Kovi Bessoff, Thomas Spangenberg, Jenna E. Foderaro et al. · Antimicrobial Agents and Chemotherapy · 2014 · 77 citations · Full text
Bicyclic azetidines kill the diarrheal pathogen <i>Cryptosporidium</i> in mice by inhibiting parasite phenylalanyl-tRNA synthetase
Sumiti Vinayak, Rajiv S. Jumani, Peter G. Miller et al. · Science Translational Medicine · 2020 · 75 citations · Full text
1–5 of 16